BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25876170)

  • 1. Acrylamide induces locomotor defects and degeneration of dopamine neurons in Caenorhabditis elegans.
    Li J; Li D; Yang Y; Xu T; Li P; He D
    J Appl Toxicol; 2016 Jan; 36(1):60-7. PubMed ID: 25876170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.
    Jadiya P; Khan A; Sammi SR; Kaur S; Mir SS; Nazir A
    Biochem Biophys Res Commun; 2011 Oct; 413(4):605-10. PubMed ID: 21925152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tris(2-chloroethyl) phosphate (TCEP) and tris(2-chloropropyl) phosphate (TCPP) induce locomotor deficits and dopaminergic degeneration in
    Xu T; Li P; Wu S; Lei L; He D
    Toxicol Res (Camb); 2017 Jan; 6(1):63-72. PubMed ID: 30090477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic exposure to graphene-based nanomaterials induces behavioral deficits and neural damage in Caenorhabditis elegans.
    Li P; Xu T; Wu S; Lei L; He D
    J Appl Toxicol; 2017 Oct; 37(10):1140-1150. PubMed ID: 28418071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-specific toxicity of chronic acrylamide exposure in C. elegans.
    Murray SM; Waddell BM; Wu CW
    Neurotoxicol Teratol; 2020; 77():106848. PubMed ID: 31756371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lanthanum nitrate on behavioral disorder, neuronal damage and gene expression in different developmental stages of Caenorhabditis elegans.
    Han GC; Jing HM; Zhang WJ; Zhang N; Li ZN; Zhang GY; Gao S; Ning JY; Li GJ
    Toxicology; 2022 Jan; 465():153012. PubMed ID: 34718030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral deficits and neural damage of Caenorhabditis elegans induced by three rare earth elements.
    Xu T; Zhang M; Hu J; Li Z; Wu T; Bao J; Wu S; Lei L; He D
    Chemosphere; 2017 Aug; 181():55-62. PubMed ID: 28426941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's disease.
    Fu RH; Wang YC; Chen CS; Tsai RT; Liu SP; Chang WL; Lin HL; Lu CH; Wei JR; Wang ZW; Shyu WC; Lin SZ
    Neuropharmacology; 2014 Jul; 82():108-20. PubMed ID: 23973292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans.
    Cheon SM; Jang I; Lee MH; Kim DK; Jeon H; Cha DS
    Pharm Biol; 2017 Dec; 55(1):481-486. PubMed ID: 27937005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Parkinsonian effects of β-amyrin are regulated via LGG-1 involved autophagy pathway in Caenorhabditis elegans.
    Wei CC; Chang CH; Liao VH
    Phytomedicine; 2017 Dec; 36():118-125. PubMed ID: 29157804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-linolenic acid suppresses dopaminergic neurodegeneration induced by 6-OHDA in C. elegans.
    Shashikumar S; Pradeep H; Chinnu S; Rajini PS; Rajanikant GK
    Physiol Behav; 2015 Nov; 151():563-9. PubMed ID: 26300470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
    Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
    PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling dopamine neuron degeneration in Caenorhabditis elegans.
    Tucci ML; Harrington AJ; Caldwell GA; Caldwell KA
    Methods Mol Biol; 2011; 793():129-48. PubMed ID: 21913098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in
    Chalorak P; Sanguanphun T; Limboonreung T; Meemon K
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections of
    Kitisin T; Muangkaew W; Sukphopetch P
    Front Cell Infect Microbiol; 2022; 12():1039336. PubMed ID: 36389163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans.
    Chen KS; Menezes K; Rodgers JB; O'Hara DM; Tran N; Fujisawa K; Ishikura S; Khodaei S; Chau H; Cranston A; Kapadia M; Pawar G; Ping S; Krizus A; Lacoste A; Spangler S; Visanji NP; Marras C; Majbour NK; El-Agnaf OMA; Lozano AM; Culotti J; Suo S; Ryu WS; Kalia SK; Kalia LV
    Mol Neurodegener; 2021 Nov; 16(1):77. PubMed ID: 34772429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.
    Jadiya P; Chatterjee M; Sammi SR; Kaur S; Palit G; Nazir A
    Biochem Biophys Res Commun; 2011 Sep; 413(2):306-10. PubMed ID: 21889494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights on the age dependent neurodegeneration induced by Monocrotophos, (an organophosphorous insecticide) in Caenorhabditis elegans fed high glucose: Evidence in wild and transgenic strains.
    Salim C; Thadathil N; Muralidhara M; Rajini PS
    Comp Biochem Physiol C Toxicol Pharmacol; 2018 Sep; 211():15-24. PubMed ID: 29763691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the Cover: Harmane-Induced Selective Dopaminergic Neurotoxicity in Caenorhabditis elegans.
    Sammi SR; Agim ZS; Cannon JR
    Toxicol Sci; 2018 Feb; 161(2):335-348. PubMed ID: 29069497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-rich diet aggravates monocrotophos-induced dopaminergic neuronal dysfunction in Caenorhabditis elegans.
    Salim C; Rajini PS
    J Appl Toxicol; 2017 Jun; 37(6):772-780. PubMed ID: 27995639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.